Abstract
A single human cell contains more than 5.0 × 105 copies of long interspersed element-1 (L1), 80–100 of which are competent for retrotransposition (L1-RTP). Recent observations have revealed the presence of de novo L1 insertions in various tumors, but little is known about its mechanism. Here, we found that 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline (MeIQx), food-borne carcinogens that are present in broiled meats, induced L1-RTP. This induction was dependent on a cellular cascade comprising the aryl hydrocarbon receptor (AhR), a mitogen-activated protein kinase, and CCAAT/enhancer-binding protein β. Notably, these compounds exhibited differential induction of L1-RTP. MeIQx-induced L1-RTP was dependent on AhR nuclear translocator 1 (ARNT1), a counterpart of AhR required for gene expression in response to environmental pollutants. By contrast, PhIP-induced L1-RTP did not require ARNT1 but was dependent on estrogen receptor α (ERα) and AhR repressor. In vivo studies using transgenic mice harboring the human L1 gene indicated that PhIP-induced L1-RTP was reproducibly detected in the mammary gland, which is a target organ of PhIP-induced carcinoma. Moreover, picomolar levels of each compound induced L1-RTP, which is comparable to the PhIP concentration detected in human breast milk. Data suggest that somatic cells possess machineries that induce L1-RTP in response to the carcinogenic compounds. Together with data showing that micromolar levels of heterocyclic amines (HCAs) were non-genotoxic, our observations indicate that L1-RTP by environmental compounds is a novel type of genomic instability, further suggesting that analysis of L1-RTP by HCAs is a novel approach to clarification of modes of carcinogenesis.
Similar content being viewed by others
Introduction
Long interspersed element-1 (L1) is the most abundant transposable element, comprising approximately 17% of the human genome.1 A single cell contains more than 5.0 × 105 copies of L1, 80–100 copies of which are competent for retrotransposition (L1-RTP).1, 2 Although approximately 10% of these RTP-competent L1s are highly active, actual occurrence of L1-RTP in the germline has been estimated to be one out of every 108 births.2, 3 L1 encodes two proteins: open reading frames 1 and 2 (ORF1 and 2).3, 4 ORF1 is a 40-kDa protein present within cytoplasmic ribonucleoprotein complexes or stress granules in cytoplasm.5, 6 It acts on L1 mRNA in cis7 and functions as a chaperone of L1 mRNA.8 By contrast, ORF2 is an approximately 150-kDa protein with both reverse transcriptase9 and endonuclease10 activities. ORF2 recognizes the sequence 5′-TAAAA-3′ and induces a nick between the T and A,11, 12 leading to first-strand DNA synthesis by target site-primed reverse transcription.3, 4, 13 Notably, ORF1 and 2 complete the entire process of L1-RTP2, 3, 4, 13 and are competent for the induction of retrotransposition of non-autonomous retroelements, such as Alu14, 15 and SVA (SINE, variable numbers of tandem repeats and Alu).16
Vitullo et al.17 recently reported that the copy numbers of mouse L1 were increased during 2–4-blastomere stages. Moreover, it was demonstrated that L1-RTP suppression by blocking reverse transcriptase activity impaired further cellular division.18 These findings indicate that L1-RTP is a pivotal molecular event in early embryogenesis. However, L1-RTP in oocytes accidently causes inborn errors: >90 types of intractable diseases were identified as sporadic cases that were caused by mutagenic insertions of endogenous retroelements.3, 4, 19 Although most were due to Alu insertions, a recent review indicated the involvement of L1-RTP in 25 sporadic cases of 11 types of genetic disorder.20 Given the importance of L1-RTP during early embryogenesis, most studies of L1 have focused on germ cells and stem cells.21, 22, 23 However, recent reports of detection of de novo L1 and Alu insertions in brain tissues24, 25, 26 and various cancers27, 28, 29, 30 indicate that the mode of RTP in somatic cells is an emerging issue in terms of their biological effects.31 Intriguingly, a recent report involving use of a highly advanced genome analysis technology identified 194 de novo insertions of endogenous retroelements in 43 tumors.32 Moreover, all of the somatic insertions of L1 or Alu were detected in cancers with epithelial-cell origin, and 64 insertions were identified in 62 annotated genes, the functions of which were associated with tumor suppression. These observations suggest active involvement of RTP in carcinogenesis.32 Although the mechanism underlying RTP induction in epithelial cells remains to be elucidated, it is tempting to speculate that environmental factors are involved in the induction of cancer-related L1-RTP.
Reported inducers of L1-RTP in somatic cells include gamma irradiation,33 heavy metals34 and benzo[a]pyrene (B[a]P)35 We recently discovered 6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan photoproduct, as a potent inducer of L1-RTP.36 We also found that L1-RTP was induced during two-stage skin carcinogenesis that was initiated by 7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate.37 Interestingly, DMBA induction of L1-RTP was dependent on the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator 1 (ARNT1).38 AhR and ARNT1 are members of the basic helix-loop-helix/pas-arnt-sim (bHLH/PAS) family, which is well conserved among species39 and comprises transcription factors involved in various biological functions.40, 41 The most well-characterized function of AhR is its binding to environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin, and formation of a complex with ARNT1 (AHR complex), which is recruited to chromatin.40, 41 Notably, chromatin recruitment of the AHR complex depends on the ARNT1 nuclear localization signal.42
Here, we report that 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx), heterocyclic amines (HCAs) formed during the cooking of red meat,43, 44 induced L1-RTP. Among HCAs, PhIP and MeIQx are important because their levels are high in food.45 Notably, picomolar levels of PhIP were identified in human breast milk,46 and HCAs have been shown to be carcinogenic in rodent models.47, 48, 49, 50, 51 PhIP induces carcinoma formation in colon and reproductive organs such as mammary gland and prostate,47, 48, 49 whereas MeIQx induces colon carcinoma and hepatoma.50, 51 These observations imply that humans are exposed daily to carcinogenic compounds, albeit at low concentrations.52 Here, we present data showing that L1-RTP by both compounds depends on AhR, a mitogen-activated protein kinase (MAPK), and CCAAT/enhancer-binding protein β (C/EBP-β). Interestingly, however, ARNT1 is required for MeIQx-induced L1-RTP but not PhIP-induced L1-RTP. Instead, PhIP-induced L1-RTP depends on estrogen receptor α (ERα) and AhRR, a repressor of AhR, another member of the bHLH/PAS family53 We also investigated the effects of these HCAs in transgenic mice that harbored human L1 as the transgene.37 Notably, L1-RTP in the mammary gland was selectively induced by PhIP in an ERα-dependent manner. Taken together with the fact that these compounds did not induce a cellular response that is triggered by DNA damage, we discuss that L1-RTP is a novel mode of carcinogenesis that is induced by non-genotoxic effects of environmental carcinogens.
Results
We first evaluated HCA-induced L1-RTP using a colony-formation assay, in which L1-RTP induced expression of a functional neomycin-resistant gene, and supported growth of cells cultured in the presence of neomycin. According to the experimental procedures shown in Figures 1a and b, HuH-7 human hepatoma cells were first transfected with pCEP4/L1mneoI/ColE1 (pL1-NeoR, Figure 1a),54, 55 selected with hygromycin, and then treated with PhIP or MeIQx on day 3 after transfection. Approximately 5.0 × 105 cells were treated initially with ∼7.5 μM of the synthesized acetoxy-forms of HCAs, which are activated forms of each compound43, 56 (each formula is depicted in Supplementary Figure S1). After neomycin selection, we observed 10–20 colonies on each plate (Figure 1c), indicating that the frequency of L1-RTP induction by both compounds was approximately 1 per 104 (*P<0.01). The induction of L1-RTP by each compound was also evaluated using a PCR-based assay that involved detection of a 140-bp band amplified from a functional EGFP (enhanced green fluorescent protein) cDNA in pEF06R, a reporter construct (Figure 1a).33 As shown in Figure 1d, both compounds induced L1-RTP in different cell lines, including Li-7 (human hepatoma), HepG2 (human hepatoma) and Caco-2 (colon carcinoma). We then determined whether low doses of HCAs induced L1-RTP. As shown in Figure 1e, even 3.5 pM of PhIP and MeIQx induced L1-RTP in HuH-7 cells, at a frequency of approximately 1 per 105 (Figure 1e, lanes 3 and 4) when judged by the signal densities of the 140-bp band normalized by β-actin. Importantly, no cytotoxic effects of the compounds at concentration up to 46 μM were detected (Figure 2a). Moreover, both compounds at 17.5 or 8.8 μM, respectively, did not induce expression of γ-H2AX (Figure 2b), and we detected no focus formation of γ-H2AX or phosphorylated ATM (ataxia telangiectasia mutated) upon treatment of cells with the compounds at 23 μM (Figure 2c). Taken together, these observations indicate that induction of L1-RTP by micromolar HCA levels was attributable to the non-genotoxic effects of the compounds.
To determine the mode of HCA-induced L1-RTP, we first investigated the involvement of AhR, a cellular binding molecule for these compounds.57 Initially, we tested the effects of 3′-methoxy-4′-nitroflavone (MNF), an AhR inhibitor;36, 37, 58 this compound completely blocked L1-RTP induction (Supplementary Figure S2, lanes 7 and 8). To further demonstrate this AhR dependency, we examined the effects of small interfering RNA (siRNA) on AhR. First, we confirmed that both of two different AhR siRNAs reduced the expression of endogenous protein (Figure 3a, lanes 4 and 5). The PCR-based assay was then carried out after AhR siRNA transfection. As shown in Figure 3b, the induction of L1-RTP by both HCAs was blocked by one of the AhR siRNAs ( in Figure 3a). The other AhR siRNA ( in Figure 3a) also attenuated L1-RTP (Supplementary Figure S3).
We next studied the necessity of ARNT1 for L1-RTP induction using ARNT1 siRNAs that efficiently reduced the expression of endogenous protein (a representative result of the two siRNAs is shown in Figure 3c and Supplementary Figure S4a; see also Supplementary Figure S3a for results of another ARNT1 siRNA). Similar to AhR siRNA, ARNT1 siRNA markedly reduced MeIQx-induced L1-RTP (Figure 3d, lane 11). Interestingly, however, it did not reduce PhIP-induced L1-RTP (Figure 3d, lane 12). As reported previously, we confirmed that the AhR and ARNT1 siRNAs abolished the expression of CYP1A1, a target gene expressed in response to FICZ,59 indicating that each siRNA effectively abolished the endogenous function of the AHR complex. We also investigated the involvement of AhRR in HCA-induced L1-RTP. By western blot (WB) analysis using an antibody to AhRR (αAhRR) (Figure 3e)60 we confirmed that two different AhRR siRNAs efficiently down-regulated endogenous AhRR protein. Then, we discovered that transfection of AhRR siRNA attenuated L1-RTP induction by PhIP. By striking contrast, it did not affect L1-RTP by MeIQx. Taken together, these data suggest that PhIP and MeIQx induced L1-RTP via different mechanisms.
Picomolar quantity of PhIP exerts growth-promoting effects that are ERα-dependent.52 To show the involvement of ERα in PhIP-induced L1-RTP, we determined the effects of fulvestrant, an ERα inhibitor.61 Consistent with the previous report,61 the addition of fulvestrant to the culture of MCF-7 human breast carcinoma cells down-regulated ERα expression (Figure 4a). Next, we investigated the effects of fulvestrant on the induction of L1-RTP by PhIP. Notably, fulvestrant selectively attenuated PhIP-induced L1-RTP (Figure 4b, compare lanes 3 and 7), whereas it did not attenuate MeIQx-induced L1-RTP (Figure 4b, lanes 2 and 6). We also observed that ERα siRNA completely blocked PhIP-induced L1-RTP (a representative result of the two siRNAs is shown in Figures 4c and d, lanes 11 and Supplementary Figures S3b and 4b). By striking contrast, MeIQx-induced L1-RTP was resistant to ERα siRNA. Interestingly, a non-acetoxy form of PhIP, which is present in the human diet as a major subclass,44, 45 also induced L1-RTP (Figure 4b, lane 4; Figure 4d, lane 4). Notably, L1-RTP was again blocked by inhibition of ERα (Figure 4b, lane 8; Figure 4d, lanes 8 and 12).
Based on an observation that ligand-bound AhR activates MAPKs,62 we next examined the involvement of MAPKs in HCA-induced L1-RTP. Consistent with our previous observations,36, 37, 63 L1-RTP was effectively blocked by SB202190 and SP600125, inhibitors of p38 and JNK (Janus kinase), respectively. The PCR-based assay also revealed the inhibitory effects of both compounds on L1-RTP (Supplementary Figure S5). Interestingly, WB analysis showed that the compounds markedly phosphorylated C/EBP-β, a substrate of p38 (Figure 5b, lanes 3 and 4). Moreover, AhR siRNA abrogated HCA-induced phosphorylation of C/EBP-β (Figure 5c, lanes 7 and 8), and the down-regulation of C/EBP-β siRNA attenuated HCA-induced L1-RTP (Figure 5d, lanes 11 and 12 and Supplementary Figures S3c and 4c). These data strongly suggest that both AhR-dependent activation of MAPKs and C/EBP-β phosphorylation are involved in HCA-induced L1-RTP.
ORF1 is localized in cytoplasmic ribonucleoprotein complexes or cytoplasmic stress granules,5, 6 which prompted us to determine whether ORF1 is recruited to chromatin upon exposure of cells to HCAs. To demonstrate this, we performed a subcellular fractionation analysis of ORF1 after transfection of expression vectors encoding a chimeric ORF1-TAP protein.64 When the transfectants were treated with MeIQx or PhIP, the amount of ORF1 in the chromatin-rich fraction was increased without apparent changes in the total amount of ORF1 (Figure 6a, lanes 2 and 3). Notably, ORF1 was detected only when the nuclear-insoluble fractions were treated with micrococcal nuclease (Figure 6b, lanes 11 and 12). Notably, HCA-induced chromatin recruitment of ORF1 was blocked by both AhR siRNA (a representative result of the two siRNAs is shown in Figure 6c, lanes 5 and 6 and Supplementary Figure S6a) and MAPK inhibitors (Figure 6d, lanes 5, 6, 8 and 9). Moreover, the PhIP-induced chromatin recruitment of ORF1 was blocked by AhRR siRNA (a representative result of the two siRNAs is shown in Figure 6e, lanes 6 and Supplementary Figure S6b) and fulvestrant (Figure 6f, lane 6).
The chromatin recruitment of ORF1 suggests its association with ERα. To investigate this possibility, we transfected MCF-7 cells with pORF1-EGFP encoding a chimeric ORF1-EGFP protein, treated them with HCAs and performed immunoprecipitation (IP) followed by WB analysis. IP with αERα followed by WB analysis with αEGFP definitely revealed that ORF1 associated with ERα upon PhIP treatment (Figure 7a, lane 6, arrow). However, this was not the case for MeIQx (lane 5). Moreover, a reciprocal experiment, in which IP was performed using αEGFP followed by WB analysis using αERα, detected the interaction of ORF1 and ERα in PhIP-treated cells (Figure 7b, lane 6, arrow). We next determined whether ORF1 formed a complex with C/EBP-β. IP-WB analysis using expression vectors encoding streptag-ORF1 (pST-ORF1) and flag-tagged C/EBP-β (pFlag-C/EBP-β) revealed that these two molecules were constitutively associated (Figure 7c, lane 4, Be: bead). By contrast, flag-tagged ovalbumin (OVA) was not associated with ST-ORF1 under the same conditions (lane 2), indicating that the interaction of these molecules was not due to a non-specific binding property of ORF1. Conversely, a reciprocal experiment confirmed the association of C/EBP-β and ORF1 (Figure 7d). Taken together, these data indicate that ORF1 constitutively forms a complex with C/EBP-β and that it can associate with ERα in response to the addition of PhIP.
To examine whether the HCAs induced L1-RTP in vivo, we used hL1-EGFP mice (No. 4 and No. 67).37 In our previous work, we proved that these mice were suitable for studying the modes of L1-RTP in somatic cells, because these mice possessed low background of L1-RTP during embryogenesis, but they responded for induction of L1-RTP in response to environmental carcinogens.37 When the mice were injected intraperitoneally with 3 nM of HCAs three times (estimated in blood concentration), L1-RTP was detected in the bone marrow (Figure 8a). Notably, PhIP induced L1-RTP in the mammary gland and colon, whereas MeIQx induced L1-RTP in the liver, spleen and gastric mucosa (one representative result of three independent experiments are shown). To determine whether HCA-induced L1-RTP is also dependent on the AhR gene, we used homozygous null AhR (AhR−/−) mice.65 No induction of HCA-induced L1-RTP was observed in No. 4h L1-EGFP/AhR−/− mice (Figure 8b, lanes 8 and 9) or in No. 67 hL1-EGFP/AhR−/− mice (Supplementary Figure S7). To exclude the possibility that hL1-EGFP/AhR−/− mice possessed defective cellular machinery required for the induction of L1-RTP, we examined the induction of L1-RTP by FICZ. Consistent with our previous observation that FICZ-induced L1-RTP was not AhR-dependent36 the administration of FICZ robustly induced L1-RTP in the thymus, lymph node and liver of hL1-EGFP/AhR−/− mice (Supplementary Figure S8). The data indicate that L1-EGFP/AhR−/− mice were competent for L1-RTP and HCA-induced L1-RTP was AhR-dependent. Interestingly, L1-RTP was occasionally identified in hL1-EGFP/AhR+/− mice (Figure 8b, lane 5). A plausible explanation is that the amount of AhR protein derived from the intact single allele of the AhR gene is sufficient for the induction of L1-RTP.
We further tested whether lower doses of the HCAs resulted in induction of L1-RTP. After 3 pM of the HCAs were injected intraperitoneally three times per week for 6 weeks, mammary gland, colon and liver tissues were subjected to the PCR-based assay. As shown in Figure 8c, PhIP induced L1-RTP in the mammary gland and colon (lanes 9 and 15). Several independent experiments indicated that the repetitive administration of low doses of PhIP reproducibly induced L1-RTP in the mammary gland, whereas MeIQx did not (Table 1, P<0.0001). To demonstrate that an orally administered compound is also capable of induction of L1-RTP, we directly injected PhIP into the stomach and evaluated the presence of L1-RTP in the mammary gland. Administration of PhIP of both 6 (Figure 8d, left panel) and 1.8 (Figure 8d, right panel) μM induced L1-RTP in the mammary gland. Finally, we found that the simultaneous injection of fulvestrant abrogated PhIP-induced L1-RTP in the mammary gland (Figure 8e, lane 4).
Discussion
Recent advances in genome analysis technology have allowed determination of the numbers of de novo L1 insertions in cancers with epithelial-cell origin.32 Based on information regarding L1 integration sites, a positive role L1-RTP in carcinogenesis has been postulated.32 Although the mechanism of L1-RTP induction during carcinogenesis remains elusive, our current work supports that environmental carcinogens function as the trigger: both PhIP and MeIQx, food-borne carcinogens,43, 44 reproducibly induced L1-RTP in vitro and in vivo. However, it is important to demonstrate that L1-RTP is induced by HCAs in an endogenous setting because our current observations were obtained by the hL1-EGFP mice, in which multiple copies of human L1 were integrated as the transgene.37 One approach is to characterize L1-RTP after exposing PhIP to primary cultured human cells that are derived, for example, from mammary gland. By comparison of integration sites of L1 in PhIP-treated cells and de novo L1 insertions in breast carcinomas, it might be possible to approach roles of PhIP in carcinogenesis.
Several independent experiments revealed that PhIP selectively induced L1-RTP in the mammary gland. Fourteen out of the 16 PhIP-treated mice examined were positive for L1-RTP in the mammary gland of the hL1-EGFP mice (Table 1). By contrast, no L1-RTP was detected in the corresponding tissue of MeIQx-treated mice. Interestingly, biochemical analyses revealed that both compounds induced L1-RTP in an AhR-dependent manner; however, MeIQx-induced L1-RTP required ARNT1, whereas PhIP-induced L1-RTP did not require ARNT1 but depended on ERα (Figure 4). The requirement of ERα for PhIP-induced L1-RTP was further supported by data showing that PhIP promoted the association of ORF1 and ERα (Figure 7a). Additionally, the PhIP-induced chromatin recruitment of ORF1 was abrogated by fulvestrant (Figure 6f), implying that the dependency of PhIP-induced L1-RTP on ERα is related to the mode by which PhIP induces malignancies in reproductive organs.47, 48, 49 Also, PhIP-induced L1-RTP was AhRR-dependent (Figure 3f), and PhIP-induced recruitment of ORF1 to chromatin required AhRR (Figure 6e). AhRR was originally identified as a repressor of AhR,53 but recent studies suggested AhRR to possess additional activities that include regulatory function in mammalian reproduction.66 Further analysis may disclose a novel function of AhRR in the responses of cells to environmental carcinogens, such as PhIP.
It has been well-known that ligand-bound AhR associates with ARNT1, forms an AHR complex and is recruited to the XRE, leading to the transcription of genes, such as CYP1A1.39, 40 ARNT1 is crucial for this process, because the chromatin recruitment of the AHR complex depends on the nuclear localization signal of ARNT1.42 As L1-RTP induction by PhIP depended on AhR but not ARNT1, the mode of PhIP-induced L1-RTP is different from the classical cellular cascade of the AHR complex. Moreover, the PhIP-induced chromatin recruitment of ORF1 was dependent on AhR, AhRR and ERα (Figure 6). Data imply that the genomic loci to which ORF1 is recruited in response to PhIP differ from those determined by the AHR complex, and L1 integration sites of PhIP and MeIQx might be different (Figure 9). Further studies are required to investigate this possibility. Although it has been proposed that L1-RTP is regulated at the transcriptional level,67, 68 our analysis using methylation-specific primers69 detected no changes of the methylation status of the 5′ untranslated region of L1 before and after administration of HCAs (Supplementary Figure S9). Additionally, no apparent increase of the expression of L1-mRNA was detected after treatment of HCAs (Supplementary Figure S10). Although it is possible that HCAs transiently modulate the L1 transcript levels, HCA-induction of L1-RTP is likely regulated predominantly at the post-transcriptional level (Supplementary Figure S10).
Notably, we reported previously that environmental carcinogens, such as DMBA, 3-methylcholanthrene and B[a]P induced in an L1-RTP AhR-dependent manner.63 By contrast, FICZ, a tryptophan photoproduct that is not carcinogenic,70, 71 also exhibited L1-RTP but in an AhR-independent manner. Together with the report that AhR is required for the chemical carcinogenesis caused by B[a]P72 and that L1-RTP induces a variety of genetic alternations such as gene deletion and chromosomal translocations,54, 73 it is plausible that the AhR-dependent L1-RTP has a positive link with carcinogenesis. Moreover, L1-encoded proteins can induce RTP of other retroelements such as Alu and SVA,14, 15, 16 and non-allelic homologous recombination between Alu sequences is known to ablate various tumor-suppressor genes that include BRAC1.74, 75 These findings suggest that L1-RTP globally alternates the genome integrity of cells, providing a growth advantage in terms of cancer development. However, due to the low frequency of L1-RTP by environmental carcinogens (approximately one in every 105 cells), identification and monitoring of cells positive for L1-RTP during carcinogenesis is problematic. One approach to demonstrate the role of L1-modulated cells in carcinogenesis is to block RTP, for example, by siRNA of L1 mRNA in an organ of interest76 and evaluate the effects on cancer development.
The carcinogenic effects of HCAs have been attributed to their genotoxic activities.44, 56 However, the PhIP concentration of PhIP in human breast milk has been reported to be approximately 1 pg/ml (3.6 pM),46 and plasma HCA concentrations were in the nM range.52 Because PhIP at less than micromolar levels exhibits no genotoxic activity, the level of HCA required to induce genetic alternations remains to be clarified. Here, we demonstrated that nanomolar levels of HCAs induced L1-RTP (Table 1), but micromolar PhIP levels were not genotoxic. Moreover, repeated administration of μM levels of PhIP also induced L1-RTP in the target organ (Figure 8d, Table 1). Taken together with a proposal that low dose of PhIP exerts carcinogenic activity via ERα,52, 77 data indicate that ERα-dependent L1-RTP is a novel type of genetic instability that is induced by non-genotoxic effects of environmental compounds. Although humans are exposed to low doses of PhIP, a life-long exposure to low levels of food-borne carcinogens might lead to accumulation of cells positive for genetic alternations caused by L1-RTP.
Materials and methods
Cell culture and chemicals
HuH-7 (RCB1366), HepG2 (RCB1886), HEK293T (RCB2202), MCF-7 (RCB1904), Li-7 (RCB1941), Caco-2 (RCB0988) (Riken BioResource Center Cell Bank, Tsukuba, Ibaraki, Japan) and HT1080 (JCRB9113; The Health Science Resources Bank, Tokyo, Japan) were maintained at 37 °C and 5% CO2 in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum. Aetoxy-forms of HCAs (PhIP: molecular weight 286.3, MeIQx: molecular weight 275.2) were synthesized (NARD Institute, Amagasaki, Hyogo, Japan). Non-acetoxy form PhIP (molecular weight 224.3) was from Toronto Research Chemicals Inc. Other reagents, primary and secondary antibodies used in the current studies are described in Supplementary Information.
L1-RTP assays
L1-RTP was assayed as described previously,36, 37 using pCEP4/L1mneoI/ColE1 (pL1-NeoR)54, 55 and pEF06R33 for colony-formation assay and a PCR-based assay, respectively. For the colony-formation assay, the cells were cultured in the presence of 800 μg/ml neomycin, and numbers of neomycin-resistant (NeoR) colonies were counted. For the PCR-based assay, DNA was extracted from cells that were treated with the compounds for 2 days (36, 38, Supplementary information). For amplification of EGFP cDNA, 5′-ACTGGGTGCTCAGGTAGTGGTT-3′ and 5′-GAAGAACGGCATCAAGGTGAA-3′ were used as PCR forward and reverse primers, respectively. The forward and reverse PCR primers for detecting human β-actin gene were 5′-TGAACCCCAAGGCCAACCGC-3′ and 5′-TTGTGCTGGGTGCCAGGGCA-3′, respectively. For mouse β-actin gene, 5′-GAGGGAAATCGTGCGTGAC-3′ and 5′-AGAAGGAAGGCTGGAAA-3′ were used. The conditions of PCR amplification of EGFP cDNA and β-actin are described in Supplementary Information of full-methods.
Transfection of plasmid DNA and siRNAs
In all, 8 μg of plasmid DNA was transfected into HuH-7, HepG2, HEK293T, Li-7, Caco-2 and HT1080 using Lipofectamine 2000, whereas it was transfected into MCF-7 cells using Xfect (TAKARA, Otsu, Shiga, Japan). siRNAs were synthesized by Applied Biosystems (Tokyo, Japan). Nucleotide sequence of each siRNA was shown in Supplementary Table S1. As control, Silencer Negative Control siRNA No. 2 (Cat No. AM4637, Life Technologies Corporation, Calsbad, CA, USA) was used. HuH-7 or MCF-7 cells were transfected with 25–100 nM siRNAs using Lipofectamine 2000 (Life Technologies Corporation) or Xfect, respectively. For WB analysis, cell extracts were prepared, as described.36, 37
IP assay and immunohistochemical analysis
IP assay was carried out, according to the reported method36, 37 To express ORF1-EGFP, ST-ORF1, flag-tagged C/EBP-β, flag-tagged OVA and ST-EGFP, we constructed pORF1-EGPF, pST-ORF1, pFlag-C/EBP-β, pFlag-OVA and pST-EGFP. Cells were suspended in IP buffer composed of 20 mM Tris–HCl (pH 7.6), 5 mM EDTA, 150 mM NaCl, 0.5% NP-40 and 10% glycerol. Each 500 μg of cell extract was reacted with 4 μg of αAhR or αEGFP and then recovered with protein G beads (GE Healthcare, Bio-Sciences Corp., Piscataway, NJ, USA). To analyze the association of ORF1 and C/EBP-β, antibodies against Flag-tag, EGFP and ORF1 were first reacted, and then immune complexes were recovered with Dynabeads protein G or Dynabeads M-280 streptavidin beads (Life Technologies Corporation). As an input sample, about one-tenth of each extract subjected to IP was loaded onto SDS–PAGE and simultaneously analyzed. The immunohistochemical analysis was done by the reported method.37
HCA-induced chromatin recruitment of ORF1
ORF1 was expressed as a chimeric protein of TAP (tandem affinity purification protein)64 (EUROSCARF: European Saccahromyces Cerevisiae Archives for Functional Analysis). To express ORF1-TAP and EGFP-TAP, pORF1-TAP and pEGFP-TAP were transfected to HuH-7 cells. The chromatin fraction was isolated using a Subcellular Protein Fractionation Kit (Thermo Scientific, Waltham, MA, USA), as described.36 Nuclear insoluble fractions were treated for 30 min with 300 U micrococcal nuclease (Thermo Scientific) at 37 °C and centrifuged for 10 min. After centrifugation at 16 000 g, recovered supernatant was subjected to WB analysis.
Experiments using hL1-EGFP mice
We used hL1-EGFP transgenic mice of lines No. 4 and No. 67 that had low background of spontaneous L1-RTP during embryogenesis.37 Each mouse was crossed with heterozygous Ahr-deficient (Ahr+/−) mice65 (Riken Bioresource Center). Then, hL1-EGFP Ahr+/− mice were mated with Ahr+/− mice to generate homozygous null mutant mice (hL1-EGFP/Ahr−/−) that carried the hL1-EGFP transgene. Genotyping was performed using DNA extracted from tails. HCAs or the same amount of dimethylsulfoxide (DMSO) were administered intraperitoneally once 2 days. On day 2 after the last injection, mice were killed and the PCR-based assay was done on extracted DNA. To evaluate effects of orally administered PhIP, approximately 3.3 or 1 μg of the compound, which were prepared in 100 μl of saline, were directly injected into the stomach of the mouse six or six times, respectively. Maximum blood concentrations estimated by these doses were of micromolar levels, respectively. As control, the same amount of DMSO was injected. During experiments, no changes in body weight of mice were detected. All animal experiments were approved by the Animal Care and Use Committee of the NCGM Research Institute and conducted in accordance with institutional procedures.
Protocol of administration of fulvestrant into hL1-EGFP mice
Effects of 7.7 mg/kg of fulvestrant on the induction of L1-RTP by PhIP were evaluated. Fulvestrant was intraperitoneally injected 4 h before administration of PhIP. The similar regimens of administration were repeated three times once 2 days. On day 2 after the last injection, genomic DNA extracted from each organ was subjected to the PCR-based assay.
Statistics
Statistical significance was evaluated using Mann–Whitney U test. Numbers of test samples were more than four. Values of <0.05 were considered to be statistically significant.
References
Bannert N, Kurth R . Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA 2004; 101: 14572–14579.
Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 2003; 100: 5280–5285.
Goodier JL, Kazazian HH . Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008; 135: 23–35.
Babushok DV, Kazazian HH . Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat 2007; 28: 527–539.
Hohjoh H, Singer MF . Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. EMBO J 1996; 15: 630–639.
Goodier JL, Zhang L, Vetter MR, Kazazian HH . LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol 2007; 27: 6469–6483.
Wei W, Gilbert N, Ooi SL, Lawler JF, Ostertag EM, Kazazian HH et al. Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol 2001; 21: 1429–1439.
Martin SL, Cruceanu M, Branciforte D, Wai-Lun Li P, Kwok SC, Hodges RS et al. LINE-1 retrotransposition requires the nucleic acid chaperone activity of the ORF1 protein. J Mol Biol 2005; 348: 549–561.
Mathias SL, Scott AF, Kazazian HH, Boeke JD, Gabriel A . Reverse transcriptase encoded by a human transposable element. Science 1991; 254: 1808–1810.
Feng Q, Moran JV, Kazazian HH, Boeke JD . Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996; 87: 905–916.
Jurka J . Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci USA 1997; 94: 1872–1877.
Gilbert N, Luts S, Morrish TA, Moran JV . Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol 2005; 25: 7780–7795.
Gasior SL, Wakeman TP, Xu B, Deininger PL . The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol 2006; 357: 1383–1393.
Dewannieux M, Esnault C, Heidmann T . LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 2003; 35: 41–48.
Wallace N, Wagstaff BJ, Deininger PL, Roy-Engel AM . LINE-1 ORF1 protein enhances Alu SINE retrotrasposition. Gene 2008; 419: 1–6.
Raiz J, Damert A, Chira S, Held U, Klawitter S, Hamdorf M et al. The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res 2012; 40: 1666–1683.
Vitullo P, Sciamanna I, Baiocchi M, Sinibaldi-Vallebona P, Spadafora C . LINE-1 retrotransposon copies are amplified during murine early embryo development. Mol Reprod Dev 2012; 79: 118–127.
Beraldi R, Pittoggi C, Sciamanna I, Mattei E, Spadafora C . Expression of LINE-1 retroposons is essential for murine preimplantation development. Mol Reprod Dev 2006; 73: 279–287.
Belancio VP, Hedges DJ, Deininger P . Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res 2008; 18: 343–358.
Hancks DC, Kazazian HH . Active human retrotransposons: variation and disease. Curr Opin Genet Dev 2012; 22: 191–203.
Georgiou I, Noutsopoulos D, Dimitriadou E, Markopoulos G, Apergi A, Lazaros L et al. Retrotransposon RNA expression and evidence for retrotransposition events in human oocytes. Hum Mol Genet 2009; 18: 1221–1228.
Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM et al. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev 2009; 23: 1303–1312.
Macia A, Muñoz-Lopez M, Cortes JL, Hastings RK, Morell S, Lucena-Aguilar G et al. Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol Cell Biol 2011; 31: 300–316.
Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, Lovci MT et al. L1 retrotransposition in human neural progenitor cells. Nature 2009; 460: 1127–1131.
Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA, De Sapio F et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 2011; 479: 534–537.
Coufal NG, Garcia-Perez JL, Peng GE, Marchetto MC, Muotri AR, Mu Y et al. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci USA 2011; 108: 20382–20387.
Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM . Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 1988; 333: 87–90.
Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 1992; 52: 643–645.
Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 2010; 141: 1253–1261.
Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011; 331: 593–596.
Kazazian HH . Mobile DNA transposition in somatic cells. BMC Biol 2011; 29: 62.
Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ et al. Landscape of Somatic Retrotransposition in Human Cancers. Science 2012; 337: 967–971.
Farkash EA, Kao GD, Horman SR, Prak ET . Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay. Nucleic Acids Res 2006; 34: 1196–1204.
Kale SP, Moore L, Deininger PL, Roy-Engel AM . Heavy metals stimulate human LINE-1 retrotransposition. Int J Environ Res Public Health 2005; 2: 14–23.
Stribinskis V, Ramos KS . Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen. Cancer Res 2006; 66: 2616–2620.
Okudaira N, Iijima K, Koyama T, Minemoto Y, Kano S, Mimori A et al. Induction of long interspersed nucleotide element-1 (L1) retrotransposition by 6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan photoproduct. Proc Natl Acad Sci USA 2010; 107: 18487–18492.
Okudaira N, Goto M, Yanobu-Takanashi R, Tamura M, An A, Abe Y et al. Involvement of retrotransposition of long interspersed nucleotide element-1 in skin tumorigenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate. Cancer Sci 2011; 102: 2000–2006.
Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA et al. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991; 252: 954–958.
Hahn ME . Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact 2002; 141: 131–160.
Beischlag TV, Luis Morales J, Hollingshead BD, Perdew GH . The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 2008; 18: 207–250.
McIntosh BE, Hogenesch JB, Bradfield CA . Mammalian Per-Arnt-Sim proteins in environmental adaptation. Annu Rev Physiol 2010; 72: 625–645.
Eguchi H, Ikuta T, Tachibana T, Yoneda Y, Kawajiri K . A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J Biol Chem 1997; 272: 17640–17647.
Wiseman M . The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67: 253–256.
Sugimura T, Wakabayashi K, Nakagama H, Nagao M . Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 2004; 95: 290–299.
Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS . Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 1995; 16: 39–52.
Scott KA, Turesky RJ, Wainman BC, Josephy PD . Hplc/electrospray ionization mass spectrometric analysis of the heterocyclic aromatic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in human milk. Chem Res Toxicol 2007; 20: 88–94.
Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1991; 12: 1503–1506.
Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997; 57: 195–198.
Nakai Y, Nelson WG, De Marzo AM . The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res 2007; 67: 1378–1384.
Nishikawa A, Imazawa T, Kuroiwa Y, Kitamura Y, Kanki K, Ishii Y et al. Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment. Toxicol sci 2005; 84: 243–248.
Ohgaki H, Hasegawa H, Suenaga M, Sato S, Takayama S, Sugimura T . Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis 1987; 8: 665–668.
Lauber SN, Ali S, Gooderham NJ . The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis 2004; 25: 2509–2517.
Ema M, Morita M, Ikawa S, Tanaka M, Matsuda Y, Gotoh O et al. Two new members of the murine Sim gene family are transcriptional repressors and show different expression patterns during mouse embryogenesis. Mol Cell Biol 1996; 16: 5865–5875.
Gilbert N, Lutz-Prigge S, Moran JV . Genomic deletions created upon LINE-1 retrotransposition. Cell 2002; 110: 315–325.
Wei W, Morrish TA, Alisch RS, Moran JV . A transient assay reveals that cultured human cells can accommodate multiple LINE-1 retrotransposition events. Anal Biochem 2000; 284: 435–438.
Schut HA, Snyderwine EG . DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 1999; 20: 353–368.
Kleman MI, Overvik E, Mason GG, Gustafsson JA . In vitro activation of the dioxin receptor to a DNA-binding form by food-borne heterocyclic amines. Carcinogenesis 1992; 13: 1619–1624.
Fritsche E, Schäfer C, Calles C, Bernsmann T, Bernshausen T, Wurm M et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmic target for ultraviolet B radiation. Proc Natl Acad Sci USA 2007; 104: 8851–8856.
Wincent E, Bengtsson J, Mohammadi Bardbori A, Alsberg T, Luecke S, Rannug U et al. Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 2012; 109: 4479–4484.
Karchner SI, Jenny MJ, Tarrant AM, Evans BR, Kang HJ, Bae I et al. The active form of human aryl hydrocarbon receptor (AHR) repressor lacks exon 8, and its Pro 185 and Ala 185 variants repress both AHR and hypoxia-inducible factor. Mol Cell Biol 2009; 29: 3465–3477.
Osborne CK, Wakeling A, Nicholson RI . Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer 2004; 90: S2–S6.
Weiss C, Faust D, Dürk H, Kolluri SK, Pelzer A, Schneider S et al. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 2005; 24: 4975–4983.
Ishizaka Y, Okudaira N, Okamura T . Regulation of retrotransposition of long interspersed element-1 by mitogen-activated protein kinases. In: Da Silva Xavier G, (ed). Protein Kinases/Book 1. InTecOpen, Croatia, pp 187–198 ( http://www.intechopen.com/books/protein-kinases ).
Puig O, Caspary F, Rigaut G, Rutz B, Bouveret E, Bragado-Nilsson E et al. The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods 2001; 24: 218–229.
Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 1997; 2: 645–654.
Hahn ME, Allan LL, Sherr DH . Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochem Pharmacol 2009; 77: 485–497.
Woodcock DM, Lawler CB, Linsenmeyer ME, Doherty JP, Warren WD . Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J Biol Chem 1997; 272: 7810–7816.
Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010; 468: 443–446.
Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821–9826.
Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453: 65–71.
Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453: 106–109.
Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 2000; 97: 779–782.
Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G et al. Human L1 retrotransposition is associated with genetic instability in vivo. Cell 2002; 110: 327–338.
Belancio VP, Roy-Engel AM, Deininger PL . All y’all need to know ‘bout retroelements in cancer. Semin Cancer Biol 2010; 20: 200–210.
Konkel MK, Batzer MA . A mobile threat to genome stability: the impact of non-LTR retrotransposons upon the human genome. Semin Cancer Biol 2010; 20: 211–221.
Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG, Spadafora C . Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene 2007; 26: 4226–4233.
Lauber SN, Gooderham NJ . The cooked meat derived genotoxic carcinogen 2-amino-3-methylimidazo[4,5-b]pyridine has potent hormone-like activity: mechanistic support for a role in breast cancer. Cancer Res 2007; 67: 9597–9602.
Acknowledgements
We are grateful to Drs Elena. T Luning Prak (University of Pennsylvania Medical Center), Gilbert Nicolas (University of Michigan Medical School) and Gabriele Vielhaber (Symrise, Germany) for providing pEF06R, pCEP4/L1mneoI/ColE1 and MNF, respectively. An antibody to AhRR was a kind gift from Dr Mark E Hahn (Woods Hole Oceanographic Institution). This work was supported in parts by a Grant-in-Aid for Research from the Ministry of Health, Labor and Welfare of Japan (09156296), and a research grant for the Log-range Research Initiative (LRI) from Japan Chemical Industry Association (JCIA). NO was an applicant supported by Grant-in-Aid from the Tokyo Biochemical Research Foundation. This work was supported in part by a Joint-Use Research facility, Hyogo College of Medicine.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
About this article
Cite this article
Okudaira, N., Okamura, T., Tamura, M. et al. Long interspersed element-1 is differentially regulated by food-borne carcinogens via the aryl hydrocarbon receptor. Oncogene 32, 4903–4912 (2013). https://doi.org/10.1038/onc.2012.516
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.516
Keywords
This article is cited by
-
Resveratrol blocks retrotransposition of LINE-1 through PPAR α and sirtuin-6
Scientific Reports (2022)
-
Effects of As2O3 on DNA methylation, genomic instability, and LTR retrotransposon polymorphism in Zea mays
Environmental Science and Pollution Research (2015)